Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY) Q3 2025 Earnings

31JulConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.92

-0.76

-0.6

-0.44

Details

Expected EPS

-0.543709

Actual EPS

-0.51

Surprise EPS

0.03

Surprise Percent

+6.2%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -0.51 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.